KPI Therapeutics, a clinical stage biotechnology company presented promising pre-clinical animal results using drugs from its platform of novel Kv1.
Teleophthalmology May Expand Coverage in Emergency Eye Care
Use of teleophthalmology could help close the coverage gap in emergency eye care, according to a new study. Medscape Medical News
New insights into human tears could lead to more comfortable contact lenses
When contact lenses work really well, you forget they are on your eyes. You might not feel the same at the end of a long day staring at a computer screen.
CCN5 protein reverses cardiac fibrosis in heart failure models
CCN5, a matricellular protein, has been found to reverse established cardiac fibrosis in heart failure models, according to a study led by Roger J. Hajjar, MD, Professor of Medicine and Director of the Cardiovascular Research Center at the Icahn School…
Announcement on Proposed Conversion of Japanese Subsidiary into the Holding Company of Acucela Inc. through Triangular Merger, Application for Listing of Shares as a Domestic Company, and Partial Amendment to the Bylaws of Acucela Inc.
SEATTLE–(BUSINESS WIRE)–Acucela Inc. (located in Seattle, Washington, U.S.A.; the “Company”) (TOKYO:4589), a clinical stage ophthalmology company that specializes in identifying and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases, has unanimously resolved at its board of directors meeting held on March 28, 2016 (Pacific Daylight Time) to (i) convert Acucela Japan Kabushiki Kaisha (the “Japan Holding Company”), which was established as a
Uncategorized
Minimal regression seen after intrastromal astigmatic keratotomy
Femtosecond laser-assisted cataract surgery with and without non-penetrating femtosecond laser intrastromal astigmatic keratotomy both yielded “small but statistically significant” regressions in surgically induced astigmatism over time, according to a study.The prospective study included 263 eyes that underwent femtosecond laser-assisted cataract surgery; 87 eyes underwent concurrent intrastromal astigmatic keratotomy (ISAK) and a comparator group of 176 eyes did not.